Publications by authors named "Luise Graichen"

Claim this Profile
N
Neutralizing activity against bovine H5N1 HPAIV (clade 2.3.4.4b) in human plasma after seasonal influenza vaccination.
Lu Zhang, Georg M N Behrens, Amy Kempf, Inga Nehlmeier, Sabine Gärtner, Luise Graichen

Emerg Microbes Infect· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Host cell entry efficiency and neutralization sensitivity of the SARS-CoV-2 MC.10.1 variant.
Lu Zhang, Amy Kempf, Inga Nehlmeier, Nianzhen Chen, Luise Graichen

Virology· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Entorhinal grid-like codes for visual space during memory formation.
Luise P Graichen, Magdalena S Linder, Lars Keuter, Ole Jensen, Christian F Doeller

Nat Commun· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amino acid residues 655 and 969 in the spike protein of Omicron subvariant BA.1 control use of TMPRSS2 versus Cathepsin L dependent entry pathways and cell tropism.
Cheila Rocha, Prerna Arora, Lu Zhang, Anzhalika Sidarovich, Luise Graichen

PLoS One· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Host cell lectins ASGR1 and DC-SIGN jointly with TMEM106B confer ACE2 independence and imdevimab resistance to SARS-CoV-2 pseudovirus with spike mutation E484D.
Prerna Arora, Lu Zhang, Inga Nehlmeier, Amy Kempf, Luise Graichen

J Virol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acquisition of a multibasic cleavage site does not increase MERS-CoV entry into Calu-3 human lung cells.
Markus Hoffmann, Hannah Kleine-Weber, Luise Graichen, Inga Nehlmeier, Amy Kempf

J Virol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ACE2-independent sarbecovirus cell entry can be supported by TMPRSS2-related enzymes and can reduce sensitivity to antibody-mediated neutralization.
Lu Zhang, Hsiu-Hsin Cheng, Nadine Krüger, Bojan Hörnich, Luise Graichen

PLoS Pathog· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid spread of the SARS-CoV-2 JN.1 lineage is associated with increased neutralization evasion.
Lu Zhang, Alexandra Dopfer-Jablonka, Anne Cossmann, Metodi V Stankov, Luise Graichen

iScience· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Virological Traits of the SARS-CoV-2 BA.2.87.1 Lineage.
Lu Zhang, Alexandra Dopfer-Jablonka, Inga Nehlmeier, Amy Kempf, Luise Graichen

Vaccines (Basel)· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2 BA.2.86 enters lung cells and evades neutralizing antibodies with high efficiency.
Lu Zhang, Amy Kempf, Inga Nehlmeier, Anne Cossmann, Anja Richter, Luise Graichen

Cell· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Entorhinal grid-like codes and time-locked network dynamics track others navigating through space.
Isabella C Wagner, Luise P Graichen, Boryana Todorova, Andre Lüttig, David B Omer

Nat Commun· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Host Cell Entry and Neutralization Sensitivity of SARS-CoV-2 Lineages B.1.620 and R.1.
Anzhalika Sidarovich, Nadine Krüger, Cheila Rocha, Luise Graichen, Amy Kempf

Viruses· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The SARS-CoV-2 Delta-Omicron Recombinant Lineage (XD) Exhibits Immune-Escape Properties Similar to the Omicron (BA.1) Variant.
Prerna Arora, Lu Zhang, Cheila Rocha, Luise Graichen, Inga Nehlmeier

Int J Mol Sci· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficient antibody evasion but reduced ACE2 binding by the emerging SARS-CoV-2 variant B.1.640.2.
Prerna Arora, Amy Kempf, Inga Nehlmeier, Luise Graichen, Sebastian Schulz

Cell Mol Immunol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2 Omicron sublineages show comparable cell entry but differential neutralization by therapeutic antibodies.
Prerna Arora, Lu Zhang, Nadine Krüger, Cheila Rocha, Anzhalika Sidarovich, Luise Graichen

Cell Host Microbe· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence for an ACE2-Independent Entry Pathway That Can Protect from Neutralization by an Antibody Used for COVID-19 Therapy.
Markus Hoffmann, Anzhalika Sidarovich, Prerna Arora, Nadine Krüger, Inga Nehlmeier, Luise Graichen

mBio· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2 variants C.1.2 and B.1.621 (Mu) partially evade neutralization by antibodies elicited upon infection or vaccination.
Prerna Arora, Amy Kempf, Inga Nehlmeier, Luise Graichen, Martin S Winkler

Cell Rep· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
No evidence for increased cell entry or antibody evasion by Delta sublineage AY.4.2.
Prerna Arora, Amy Kempf, Inga Nehlmeier, Luise Graichen, Martin S Winkler

Cell Mol Immunol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional analysis of polymorphisms at the S1/S2 site of SARS-CoV-2 spike protein.
Prerna Arora, Anzhalika Sidarovich, Luise Graichen, Bojan Hörnich, Alexander Hahn

PLoS One· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic.
Markus Hoffmann, Nadine Krüger, Sebastian Schulz, Anne Cossmann, Cheila Rocha, Luise Graichen

Cell· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The spike protein of SARS-CoV-2 variant A.30 is heavily mutated and evades vaccine-induced antibodies with high efficiency.
Prerna Arora, Cheila Rocha, Amy Kempf, Inga Nehlmeier, Luise Graichen

Cell Mol Immunol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Delta variant (B.1.617.2) sublineages do not show increased neutralization resistance.
Prerna Arora, Amy Kempf, Inga Nehlmeier, Luise Graichen, Anzhalika Sidarovich

Cell Mol Immunol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
B.1.617.2 enters and fuses lung cells with increased efficiency and evades antibodies induced by infection and vaccination.
Prerna Arora, Anzhalika Sidarovich, Nadine Krüger, Amy Kempf, Inga Nehlmeier, Luise Graichen

Cell Rep· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2 variant B.1.617 is resistant to bamlanivimab and evades antibodies induced by infection and vaccination.
Markus Hoffmann, Heike Hofmann-Winkler, Nadine Krüger, Amy Kempf, Inga Nehlmeier, Luise Graichen

Cell Rep· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2 mutations acquired in mink reduce antibody-mediated neutralization.
Markus Hoffmann, Lu Zhang, Nadine Krüger, Luise Graichen, Hannah Kleine-Weber

Cell Rep· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis